TEAM (Trial on Efficacy and Quality of Life Among Asthmatic Patient With Montelukast)

• Status: Completed
• Trial end date: 2018-05-30
• Target enrollment: 0
• Participant gender: All

Summary

• To compare the quality of Life using AQLQ (s) questionnaire after 4 weeks of Montelukast.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: PharmEvo Pvt Ltd
• Treatments: Montelukast

Criteria

Inclusion Criteria:

• Clinical diagnosis of Asthma

• Signed Informed Consent

Exclusion Criteria:

• Previous adverse reaction to montelukast or other leukotriene inhibitor;

• History of hyper-eosinophilic disorder other than atopic disease;

• Treatment with montelukast within 4 weeks from randomization;

• Asthma exacerbation or treatment with prednisone/other systemic steroid within 4 weeks from randomization.